Plus   Neg

EU Opens Formal Probe Against Teva For Anticompetitive Conduct - Quick Facts

The European Commission has opened a formal antitrust investigation against Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. (TEVA) to assess whether it has illegally delayed the market entry and uptake of medicines that compete with its blockbuster multiple sclerosis drug Copaxone.

The Commission will investigate whether Teva has abused a dominant market position in breach of EU antitrust rules.

Multiple sclerosis is a chronic illness affecting the daily lives of more than half a million Europeans requiring life-long treatment. Copaxone, Teva's best selling drug, is widely used for the treatment of relapsing forms of multiple sclerosis and contains the active pharmaceutical ingredient glatiramer acetate.

The commission said it is paramount to preserve healthy competition in the market for available drugs that aim at slowing down multiple sclerosis and improving patients' quality of life as humanity has not yet found a treatment for this disease, which remains incurable.

If proven, Teva's behaviour may amount to an abuse of dominant position and infringe Article 102 of the Treaty on the Functioning of the European Union (TFEU) and Article 54 of the European Economic Area (EEA) Agreement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Inter-American Development Bank and Citi Innovation Labs have successfully completed a proof-of-concept to make cross-border payments from the U.S. to countries in Latin America and the Caribbean, using blockchain and tokenized money. The platform provided full traceability of the transactions, exchange rates, and fees on blockchain. Australian competition regulator said the country's Federal Court found that Google and its Australian arm misled users about the collection and use of personal location data. The data was collected through Android mobile devices between January 2017 and December 2018. This is said to be the world-first enforcement action brought by the Australian Competition and Consumer Commission or ACCC. Morgan Stanley (MS) reported a first-quarter profit that more than doubled from last year, reflecting strong performance across all of its business segment. Net revenues for the quarter grew 61 percent from the previous year. Quarterly adjusted earnings per share beat analysts' estimates.
Follow RTT